205 related articles for article (PubMed ID: 33670079)
21. Biomarkers of β-Cell Stress and Death in Type 1 Diabetes.
Mirmira RG; Sims EK; Syed F; Evans-Molina C
Curr Diab Rep; 2016 Oct; 16(10):95. PubMed ID: 27541297
[TBL] [Abstract][Full Text] [Related]
22. Detection of islet β-cell death in vivo by multiplex PCR analysis of differentially methylated DNA.
Fisher MM; Perez Chumbiauca CN; Mather KJ; Mirmira RG; Tersey SA
Endocrinology; 2013 Sep; 154(9):3476-81. PubMed ID: 23825129
[TBL] [Abstract][Full Text] [Related]
23. Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes.
Yang BT; Dayeh TA; Volkov PA; Kirkpatrick CL; Malmgren S; Jing X; Renström E; Wollheim CB; Nitert MD; Ling C
Mol Endocrinol; 2012 Jul; 26(7):1203-12. PubMed ID: 22570331
[TBL] [Abstract][Full Text] [Related]
24. Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans.
Cinti F; Mezza T; Severi I; Suleiman M; Cefalo CMA; Sorice GP; Moffa S; Impronta F; Quero G; Alfieri S; Mari A; Pontecorvi A; Marselli L; Cinti S; Marchetti P; Giaccari A
Metabolism; 2021 Jan; 114():154414. PubMed ID: 33129839
[TBL] [Abstract][Full Text] [Related]
25. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
26. Fasting serum total bile acid levels are associated with insulin sensitivity, islet β-cell function and glucagon levels in response to glucose challenge in patients with type 2 diabetes.
Wang XH; Xu F; Cheng M; Wang X; Zhang DM; Zhao LH; Cai HL; Huang HY; Chen T; Zhang XL; Wang XQ; Cheng XB; Su JB; Lu Y
Endocr J; 2020 Nov; 67(11):1107-1117. PubMed ID: 32684527
[TBL] [Abstract][Full Text] [Related]
27. Comparison of β-cell dysfunction and insulin resistance correlating obesity with type 2 diabetes: A cross-sectional study.
Liu J; Wang Y; Hu Y; Leng S; Wang G
J Diabetes Complications; 2016 Jul; 30(5):898-902. PubMed ID: 27012460
[TBL] [Abstract][Full Text] [Related]
28. The Beta Cell in Type 2 Diabetes.
Christensen AA; Gannon M
Curr Diab Rep; 2019 Aug; 19(9):81. PubMed ID: 31399863
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of Beta-Cell Apoptosis in Type 2 Diabetes-Prone Situations and Potential Protection by GLP-1-Based Therapies.
Costes S; Bertrand G; Ravier MA
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069914
[TBL] [Abstract][Full Text] [Related]
30. Islet β cell mass in diabetes and how it relates to function, birth, and death.
Weir GC; Bonner-Weir S
Ann N Y Acad Sci; 2013 Apr; 1281(1):92-105. PubMed ID: 23363033
[TBL] [Abstract][Full Text] [Related]
31. Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death.
Tersey SA; Nelson JB; Fisher MM; Mirmira RG
J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060259
[TBL] [Abstract][Full Text] [Related]
32. Overexpressed beta cell CART increases insulin secretion in mouse models of insulin resistance and diabetes.
Abels M; Riva M; Shcherbina L; Fischer AT; Banke E; Degerman E; Lindqvist A; Wierup N
Peptides; 2022 May; 151():170747. PubMed ID: 35065097
[TBL] [Abstract][Full Text] [Related]
33. Paraneoplastic β Cell Dedifferentiation in Nondiabetic Patients with Pancreatic Cancer.
Wang Y; Ni Q; Sun J; Xu M; Xie J; Zhang J; Fang Y; Ning G; Wang Q
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31781763
[TBL] [Abstract][Full Text] [Related]
34. (Epi)genomic heterogeneity of pancreatic islet function and failure in type 2 diabetes.
Lawlor N; Stitzel ML
Mol Metab; 2019 Sep; 27S(Suppl):S15-S24. PubMed ID: 31500827
[TBL] [Abstract][Full Text] [Related]
35. Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia.
Esser N; Utzschneider KM; Kahn SE
Diabetologia; 2020 Oct; 63(10):2007-2021. PubMed ID: 32894311
[TBL] [Abstract][Full Text] [Related]
36. Elevated Medium-Chain Acylcarnitines Are Associated With Gestational Diabetes Mellitus and Early Progression to Type 2 Diabetes and Induce Pancreatic β-Cell Dysfunction.
Batchuluun B; Al Rijjal D; Prentice KJ; Eversley JA; Burdett E; Mohan H; Bhattacharjee A; Gunderson EP; Liu Y; Wheeler MB
Diabetes; 2018 May; 67(5):885-897. PubMed ID: 29436377
[TBL] [Abstract][Full Text] [Related]
37. Impact of Pdx1-associated chromatin modifiers on islet β-cells.
Spaeth JM; Walker EM; Stein R
Diabetes Obes Metab; 2016 Sep; 18 Suppl 1(Suppl 1):123-7. PubMed ID: 27615141
[TBL] [Abstract][Full Text] [Related]
38. Reduced Expression of the Co-regulator TLE1 in Type 2 Diabetes Is Associated with Increased Islet α-Cell Number.
Armour SL; Anderson SJ; Richardson SJ; Ding Y; Carey C; Lyon J; Maheshwari RR; Al-Jahdami N; Krasnogor N; Morgan NG; MacDonald P; Shaw JAM; White MG
Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32065829
[TBL] [Abstract][Full Text] [Related]
39. Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes.
Yang CH; Ann-Onda D; Lin X; Fynch S; Nadarajah S; Pappas EG; Liu X; Scott JW; Oakhill JS; Galic S; Shi Y; Moreno-Asso A; Smith C; Loudovaris T; Levinger I; Eizirik DL; Laybutt DR; Herzog H; Thomas HE; Loh K
Mol Metab; 2022 Jan; 55():101413. PubMed ID: 34890851
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of the Pdx1/Ovol2/Zeb2 axis in dedifferentiated β-cells triggers the induction of genes associated with epithelial-mesenchymal transition in diabetes.
de Jesus DS; Mak TCS; Wang YF; von Ohlen Y; Bai Y; Kane E; Chabosseau P; Chahrour CM; Distaso W; Salem V; Tomas A; Stoffel M; Rutter GA; Latreille M
Mol Metab; 2021 Nov; 53():101248. PubMed ID: 33989778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
